How cardioids can usher in the next generation of drug discovery
We recently partnered with HeartBeat.bio to automate and scale the production of cardioids — 3D cell models of the heart that can more accurately recapitulate human biology.
Labiotech.eu spoke with Susan Murphy, president of Molecular Devices, to find out how cardioids can improve research accuracy and lead to greater returns on drug discovery investment, and how we plan to take our customers from 2D to 3D models in this next generation of drug discovery.